VolitionRX Ltd
VNRX
Rank in Stocks
#31842
VolitionRx Limited, a multi-national epigenetics company, develops blood tests... VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.
Share Price
$0.2
Last synced: 2026-11-09
Market Cap
$2.41M
Change (1 day)
2.09%
Change (1 year)
-97.18%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade VolitionRX Ltd (VNRX)
Category
Healthcare
EPS for VolitionRX Ltd (VNRX)
EPS as of June 2026 TTM: $-3.87
According to VolitionRX Ltd's latest financial reports, its current EPS (TTM) is $-3.87. At the end of 2025 the company had an EPS of $-4.40, an increase over its 2024 EPS of $-6.20.
EPS history for VolitionRX Ltd from 2004 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-3.87 | -12.05% |
| 2025 | $-4.40 | -29.03% |
| 2024 | $-6.20 | -38.00% |
| 2023 | $-10.00 | -9.09% |
| 2022 | $-11.00 | 7.84% |
| 2021 | $-10.20 | 13.33% |
| 2020 | $-9.00 | 9.76% |
| 2019 | $-8.20 | -28.07% |
| 2018 | $-11.40 | 1.79% |
| 2017 | $-11.20 | 7.69% |
| 2016 | $-10.40 | -3.70% |
| 2015 | $-10.80 | -11.48% |
| 2014 | $-12.20 | 79.41% |
| 2013 | $-6.80 | -22.73% |
| 2012 | $-8.80 | -2.22% |
| 2011 | $-9.00 | 9,275.00% |
| 2010 | $-0.10 | -30.43% |
| 2009 | $-0.14 | -27.37% |
| 2008 | $-0.19 | -17.39% |
| 2007 | $-0.23 | -31.55% |
| 2006 | $-0.34 | 68.00% |
| 2005 | $-0.20 | -46.52% |
| 2004 | $-0.37 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | -169.77% |
US
|
|
| $4.09 | -205.68% |
IE
|
|
| $9.45 | -344.19% |
US
|
|
| $2.37 | -161.24% |
US
|
|
| $1.77 | -145.74% |
US
|
Questions about VolitionRX Ltd's earnings per share (EPS)
What is VolitionRX Ltd's earnings per share (EPS)?
VolitionRX Ltd's earnings per share (EPS) over the last twelve months is $-3.87, as of Jun 2026.
What was VolitionRX Ltd's earnings per share (EPS) in 2025?
In 2025, VolitionRX Ltd's earnings per share (EPS) was $-4.40, compared with $-6.20 in 2024.
How has VolitionRX Ltd's earnings per share (EPS) changed since 2020?
From 2020 to 2025, VolitionRX Ltd's earnings per share (EPS) was highest in 2025 ($-4.40) and lowest in 2022 ($-11.00).
How does VolitionRX Ltd's earnings per share (EPS) compare with similar companies?
VolitionRX Ltd's earnings per share (EPS) ($-3.87) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.